Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LARGE1 antisense RNA 1 (LARGE1-AS1) is a long non-coding RNA gene annotated in the human genome, transcribed antisense to the LARGE1 locus, which encodes glycosyltransferase LARGE1. While other antisense lncRNAs can play regulatory roles in gene expression and chromatin dynamics, no direct functional or disease associations have been described for LARGE1-AS1 specifically. Its naming convention follows the standard for lncRNAs positioned antisense to coding genes. Published literature mentions the existence of both "LARGE-AS1" and "LARGE1-AS1", which can potentially lead to confusion, but both refer to antisense lncRNAs in the LARGE1 gene region[5]. Functional annotation and clinical significance are currently unknown. If additional functional or disease associations are desired for lncRNAs of this class, general mechanisms seen with other antisense lncRNAs include chromatin regulation, regulation of sense gene expression, and possible roles in transcriptional or post-transcriptional regulation[4][7], but such roles are not confirmed for LARGE1-AS1 and should not be ascribed absent direct evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LARGE1 antisense RNA 1 (LARGE1-AS1).